Fundraising Fox

Exai Bio Inc.

Palo Alto, US · Founded 2021 · 1 known investors

ExAI develops technology for early cancer detection, diagnosis, and management. The company serves healthcare providers and patients in the oncology space.

Founders & leadership

AP
Alexander ParkerNamed on SEC filing
HG
Hani GoodarziNamed on SEC filing
MP
Michael PelliniNamed on SEC filing
PA
Patrick A. ArensdorfNamed on SEC filing

Investors · 1

Reported raises · per SEC filings

Form D private placements
$70.6MraisedOct 2022 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alexander ParkerDirector
  • Hani GoodarziDirector
  • Michael PelliniDirector
  • Patrick A. ArensdorfExecutive Officer, Director
Offering amount
$71.5M
Amount sold
$70.6M
First sale
Sep 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Exai Bio Inc. do?
ExAI develops technology for early cancer detection, diagnosis, and management. The company serves healthcare providers and patients in the oncology space.
Who are Exai Bio Inc.'s investors?
Exai Bio Inc.'s investors include Amplify Partners.
Where is Exai Bio Inc. headquartered?
Exai Bio Inc. is headquartered in Palo Alto, US.